The Gut Microbiota-Associated Metabolite Network in Ischemic Stroke: From Pathophysiological Imbalance to Potential Precision Intervention Strategies.
Abstract Ischemic stroke (IS) remains a leading cause of death and long-term neurological disability worldwide, and current treatment options are constrained by narrow therapeutic windows and limited neuroprotective efficacy. Accumulating evidence implicates the microbiota-gut-brain axis (MGBA) in the development and progression of IS. Following cerebral ischemia, bidirectional communication between the brain and gut is disrupted, resulting in gut microbial dysbiosis, impaired intestinal barrie...